Temple Researchers and Biotech Spinoff Chase an HIV Cure By Mark TerryMay 4, 2023 Three people have been known to have been “cured” of HIV, meaning that the virus was [….]
Temple Researchers and Biotech Spinoff Chase an HIV Cure
HIV Functional Cure Momentum Builds as American Gene Technologies Approaches Data Readout
After achieving several important clinical milestones, momentum and excitement has been building for months around the company’s lead pipeline candidate AGT103-T, which is a potential HIV functional cure. In the coming months, the company expects to have the latest data readout for its Phase I trial. AGT103-T is a single-dose HIV gene therapy that could potentially replace antiretroviral therapy (ART) with a functional cure.
Here’s Why the First Cure for HIV Could Emerge from Maryland
Here’s Why the First Cure for HIV Could Emerge from Maryland These Five Life Science Organizations are Striving for an HIV Cure October 3, 2023 For those that lived through [….]